- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04891341
Investigation of the Effects of Technology Supported Different Physiotherapy Approaches on Patients With Multiple Sclerosis
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Altındağ
-
Ankara, Altındağ, Turkey, 06100
- Mert Doğan
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnosed with Relapsing Remitting, Primary Progressive or Secondary Progressive MS according to McDonald criteria,
- Between the age of 18 and 50 years
- EDSS score greater than 2, less than 5.5,
- Mini Mental State Test score of 24 and above,
- Volunteers who have access to smartphone (mobile phone) through themselves or their relatives will be included in the study.
Exclusion Criteria:
- Surgery or botox application for spasticity in the last 6 months,
- Having an attack history in the last 3 months,
- Received physical therapy and rehabilitation services in the last 6 months,
- Any pain in any part of the body, previous surgery, any orthopedic problem,
- Have a secondary neurological, orthopedic or systematic condition that prevents standing independently,
- With severe peripheral vestibular involvement,
- EDSS- Pyramidal functions score equal to and greater than 4,
- Patients who do not agree to participate in the study and do not give written consent will not be included in the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Technology Supported Task-Oriented Circuit Therapy Group
Ten workstations, which are frequently used in the literature and determined according to the clinical experience of the research team, have been created.
Each workstation will be applied for a total of 1 hour, in the form of 5 minutes of training and 1 minute of rest.
|
Ten workstations, which are frequently used in the literature and determined according to the clinical experience of the research team, have been created. Each workstation will be applied for a total of 1 hour, in the form of 5 minutes of training and 1 minute of rest.
|
|
ACTIVE_COMPARATOR: Home-based Telerehabilitation Group
To the telerehabilitation group; A home program consisting of strengthening, balance and coordination exercises determined according to the needs of volunteers with MS will be given.
A session will be applied in the home program under the guidance of a physiotherapist.
The exercise will take 1 hour.
The exercise participation status of the patient will be monitored with a mobile (smartphone) application.
Exercises will be constantly updated according to the needs of the patient, the updated exercises will be sent to the mobile application via video, and the patient will be able to communicate with the physiotherapist via video conference whenever he / she wishes.
Progress and complication of the treatment program will be achieved by increasing the weights used, changing the ground characteristics and support surface during balance exercises and increasing the complexity of coordination exercises.
|
Strengthening, balance and coordination exercises will be sent to the participants via a mobile application.
Patients will do the exercises at home and send a notification to their physiotherapist.
Intervention will be applied for 1 hour, 3 days a week for 8 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Berg Balance Scale
Time Frame: Change between baseline and after 8 weeks treatment.
|
Berg Balance Scale will be used to determine the balance exposure level of the volunteers.
It is a scale that includes the performance of 14 different tasks between 0 (not applicable) and 4 (normal performance).
In this scale, which is evaluated over 56 points; Scores between 0 and 20 indicate imbalance, scores between 21 and 40 indicate that the balance is acceptable, and scores between 41 and 56 indicate that the balance is good.
|
Change between baseline and after 8 weeks treatment.
|
|
Multiple Sclerosis Quality of Life Scale (MSSQL-54)
Time Frame: Change between baseline and after 8 weeks treatment
|
Individuals' quality of life will be evaluated with MSQOL-54.
In this scale consisting of 12 chapters and 54 questions in total, physical function, social function, physical role limitations, emotional role limitations, cognitive function, pain, emotional state, energy, sexual function, health perception, general quality of life, health stress and emotional well-being.
|
Change between baseline and after 8 weeks treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Trunk Impairment Scale
Time Frame: Change between baseline and after 8 weeks treatment.
|
Trunk Impairment Scale will be used to evaluate the volunteers' trunk control.
The scale consists of 17 items, 3 of which are related to static balance, 10 to dynamic balance, and 4 to the coordination ability of the stabilizer muscles.
The scale is in the range of 0-23 points.
High scores indicate good trunk control.
|
Change between baseline and after 8 weeks treatment.
|
|
Timed Up and Go Test
Time Frame: Change between baseline and after 8 weeks treatment.
|
The Timed Get Up and Go Test will be used to evaluate the volunteers' functional mobility skills.
Volunteers are asked to sit on a chair.
A cone is placed 3 meters away from the chair in a linear fashion.
The volunteer is asked to get up, walk around the cone and sit back on the chair.
The time to complete this task will be recorded by measuring with a stopwatch.
The test will be repeated 3 times and the average time will be noted.
|
Change between baseline and after 8 weeks treatment.
|
|
Goal Assesment Scale
Time Frame: Change between baseline and after 8 weeks treatment.
|
This scale, which is widely used in patient-centered treatment approaches, includes the creation of the goal that the patient wants to reach as a result of the treatment, by the physiotherapist and the patient. The expected result is initially set as "0", -2 means the worst expected result, while +2 represents the most positive possible result. Fatigue Intensity Scale: Fatigue intensity scale will be used to evaluate fatigue. The scale consists of 9 items. Each item is rated from 1 to 7. The score of the scale is obtained by the arithmetic mean of all items. People with a score of 4 and above are considered to be tired. |
Change between baseline and after 8 weeks treatment.
|
|
ABILHAND-Stroke
Time Frame: Change between baseline and after 8 weeks treatment.
|
ABILHAND Stroke Hand Function Questionnaire will be used to question the hand functions of volunteers.
In the questionnaire, the level of difficulty perceived by the volunteers while performing activities such as feeding, dressing and housework is questioned.
The questionnaire consists of 56 items and each item is scored as 0 (impossible), 1 (difficult) and 2 (easy).
High score means good hand skills.
|
Change between baseline and after 8 weeks treatment.
|
|
Minnesota Manual Dexterity Test
Time Frame: Change between baseline and after 8 weeks treatment.
|
Minnesota Manual Dexterity test will be used to evaluate volunteers' hand agility.
Test 60 blocks; There are two stages of placement and translation.
The placement test is performed by the volunteer placing the blocks towards the distance from the target close to him, and the total time is recorded.
The placement test will be repeated for both hands.
In the flip test, the volunteer is asked to take the blocks from the corner of the dominant side with the non-dominant hand, turn them bimanually and place them with the dominant side.
The test goes from the far dominant corner to the non-dominant corner.
The second row starts on the non-dominant side and runs towards the dominant side.
At this stage, the person takes the block with the dominant hand, turns it bimanually and places it with the non-dominant side.
This is repeated in the third and fourth rows as in the first and second rows and the total time is recorded.
In the literature, it is recommended for use in patients with MS.
|
Change between baseline and after 8 weeks treatment.
|
|
Twelve Item MS Walking Scale
Time Frame: Change between baseline and after 8 weeks treatment.
|
This 12-item scale evaluates the limitations of the MS patient in walking in the last two weeks.
Scoring is made between 1-5.
In this questionnaire, in which the patient evaluates his own walking performance, a high score indicates that walking ability is affected or the patient has difficulty in walking.
|
Change between baseline and after 8 weeks treatment.
|
|
Kinematic Analysis During Functional Activities
Time Frame: Change between baseline and after 8 weeks treatment.
|
XSENS MVN-Awinda sensors will be used to measure volunteers' joint angles in different functions. This sensor system is frequently used in the literature for motion analysis. Joint angles will be measured using sensors during the following activities:
|
Change between baseline and after 8 weeks treatment.
|
|
International Cooperative Ataxia Rating Scale
Time Frame: Change between baseline and after 8 weeks treatment.
|
The scale consists of 4 sub-parameter: posture and gait disturbances, kinetic functions, speech and oculomotor disorders.
Posture and gait disturbances sub-parameter consists of 7 questions 34 points, kinetic functions 7 questions 52 points, speech disorders 2 questions 8 points, oculomotor disorders 3 questions 6 points.
The score range is 0-100, and higher scores indicate increased disease severity.
|
Change between baseline and after 8 weeks treatment.
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- E-53875521-050-713
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.